Literature DB >> 22191004

Cutaneous infections and infestations: new therapies.

Emily C Keller1, Kenneth J Tomecki.   

Abstract

Directed and preventive therapies for cutaneous infectious disease and infestation continue to evolve, providing physicians with new options for care. Common infectious diseases (e.g., genital herpes, herpes zoster, and head lice) occur in the outpatient and inpatient setting. This review of the literature highlights new therapies, including those still in development, such as novel drugs and vaccines, all of which should help to decrease the frequency and severity of common infectious diseases of the skin and subcutaneous tissues.

Entities:  

Year:  2011        PMID： 22191004      PMCID： PMC3244357     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  84 in total

1.  FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-05-28       Impact factor: 17.586

2.  Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice.

Authors:  Terri L Meinking; Maureen Vicaria; Deborah H Eyerdam; Maria Elena Villar; Susan Reyna; German Suarez
Journal:  Pediatr Dermatol       Date:  2004 Nov-Dec       Impact factor: 1.588

3.  Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.

Authors:  William J Martone; Kenneth C Lamp
Journal:  Curr Med Res Opin       Date:  2006-12       Impact factor: 2.580

Review 4.  Retapamulin: a novel topical antibiotic.

Authors:  H Nagabushan
Journal:  Indian J Dermatol Venereol Leprol       Date:  2010 Jan-Feb       Impact factor: 2.545

5.  Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.

Authors:  Michael S Simberkoff; Robert D Arbeit; Gary R Johnson; Michael N Oxman; Kathy D Boardman; Heather M Williams; Myron J Levin; Kenneth E Schmader; Lawrence D Gelb; Susan Keay; Kathleen Neuzil; Richard N Greenberg; Marie R Griffin; Larry E Davis; Vicki A Morrison; Paula W Annunziato
Journal:  Ann Intern Med       Date:  2010-05-04       Impact factor: 25.391

6.  Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.

Authors:  Lawrence Charles Parish; Joseph Lucius Jorizzo; John Jeffrey Breton; Joseph William Hirman; Nicole Elizabeth Scangarella; Ribhi Mohammad Shawar; Scott Matthew White
Journal:  J Am Acad Dermatol       Date:  2006-10-06       Impact factor: 11.527

7.  Head lice.

Authors:  Barbara L Frankowski; Joseph A Bocchini
Journal:  Pediatrics       Date:  2010-07-26       Impact factor: 7.124

8.  TAK-599, a novel N-phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties.

Authors:  Tomoyasu Ishikawa; Nobuyuki Matsunaga; Hiroyuki Tawada; Noritaka Kuroda; Yutaka Nakayama; Yukio Ishibashi; Mitsumi Tomimoto; Yukihiro Ikeda; Yoshihiko Tagawa; Yuji Iizawa; Kenji Okonogi; Shohei Hashiguchi; Akio Miyake
Journal:  Bioorg Med Chem       Date:  2003-05-29       Impact factor: 3.641

9.  Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.

Authors:  George Sakoulas; Jack Brown; Kenneth C Lamp; Lawrence V Friedrich; Kimberly C Lindfield
Journal:  Clin Ther       Date:  2009-09       Impact factor: 3.393

10.  A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.

Authors:  Woong Shick Ahn; Seung Won Huh; Su-Mi Bae; Insu P Lee; Jun Mo Lee; Sung Eun Namkoong; Chong Kook Kim; Jeong-Im Sin
Journal:  DNA Cell Biol       Date:  2003-03       Impact factor: 3.311
View more
  1 in total

1.  The Antimicrobial and Wound Healing Potential of Opuntia ficus indica L. inermis Extracted Oil from Tunisia.

Authors:  Ikram Khémiri; Badiaa Essghaier Hédi; Najla Sadfi Zouaoui; Neyla Ben Gdara; Lotfi Bitri
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-14       Impact factor: 2.629
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.